04:00 , Oct 28, 2017 |  BioCentury  |  Product Development

Chinks in the armor

Even with slowing revenues tied largely to a single product and a dearth of launches, Wall Street darling Celgene Corp. had been on an extended tear, growing its share price in excess of 300% since...
16:06 , May 4, 2017 |  BC Week In Review  |  Clinical News

FDA approves companion diagnostic for AML drug Rydapt

Invivoscribe Technologies Inc. (San Diego, Calif.) said FDA approved its Leukostrat CDx FLT3 Mutation Assay as a companion diagnostic for acute myelogenous leukemia (AML) drug Rydapt midostaurin from Novartis AG (NYSE:NVS; SIX:NOVN). The in vitro...
21:36 , Feb 24, 2017 |  BC Week In Review  |  Company News

Promega, Thermo Fisher supply/service news

The U.S. Supreme Court ruled that Life Technologies Corp. is not liable for patent infringement under U.S. law for selling Promega’s kit overseas because only one of the five components were manufactured in the U.S....
00:23 , Jan 19, 2017 |  BC Extra  |  Company News

Management tracks

Cancer company Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) named Richard Peters president and CEO, effective Feb. 6. He was SVP and head of global rare diseases at the Genzyme unit of Sanofi (Euronext:SAN; NYSE:SNY). Fibrosis and inflammation...
07:00 , Apr 7, 2016 |  BC Innovations  |  Tools & Techniques

Sexy sequencing

Tim Harris, Venture Partner, SV Life Sciences  The days when PhDs were minted based on sequencing a few nucleotides at the end of a piece of nucleic acid are definitely gone. The countless hours spent...
02:06 , Apr 2, 2015 |  BC Extra  |  Company News

Management tracks

Antibody-drug conjugate company ImmunoGen Inc. (NASDAQ:IMGN) hired Anna Berkenblit as VP and CMO. Berkenblit was SVP of clinical development at H3 Biomedicine Inc. (Cambridge, Mass.). Ear disease company Otonomy Inc. (NASDAQ:OTIC) named Dean Hakanson CMO....
07:00 , Mar 23, 2015 |  BC Week In Review  |  Company News

Enzo, Thermo Fisher genomics news

The U.S. Court of Appeals for the Federal Circuit (CAFC) vacated a lower court judgment that Life Technologies Corp .’s sequencing instruments infringed Enzo’s U.S. Patent No. 5,449,767, covering DNA sequencing compounds. The appeals court...
07:00 , Oct 27, 2014 |  BC Week In Review  |  Clinical News

Lyra Parainfluenza Assay regulatory update

Quidel said FDA granted 510(k) clearance to the company's Lyra Parainfluenza Assay to quantitatively detect human parainfluenza virus (HPIV) infections types 1, 2 or 3 viral RNA from nasal swab and nasopharyngeal swab specimens. The...
07:00 , Oct 27, 2014 |  BioCentury  |  Finance

Waiting for better times

Poised to complete the fourth-largest European biotech IPO since 2008, the road show for Molecular Partners AG had the poor luck of coinciding with the largest one-week drop in the broader capital markets since the...
07:00 , Oct 20, 2014 |  BC Week In Review  |  Clinical News

Lyra Adenovirus Assay regulatory update

Quidel said FDA granted 510(k) clearance to its Lyra Adenovirus Assay to qualitatively detect human adenovirus viral DNA isolated from nasal and nasopharyngeal swab specimens. The multiplex real-time PCR in vitro assay is available for...